On January 30, 2020, my colleague, Seth Ray, and I will present our second annual year–in-review webinar of the Food and Drug Administration’s regulation of prescription drug and medical device promotion. Seth previously served for more than 20 years in FDA’s Office of Chief Counsel and two years in the Center for Drug Evaluation and Research’s Office of Prescription Drug Promotion.
As of this writing, more than 401 sites have registered, an indication that so many in the industry want to stay informed and do their best to stay in compliance. CLE credit is likely a nice draw, and Seth’s wealth of experience at FDA will be useful to our listeners in gaining insight into “FDA thinking.”
A review of the registrant list includes not only consultants, regulatory affairs, in-house counsel, and compliance officers, but also individuals from commercial, marketing, and even Chief Executive Officers. Small, mid-size, and large companies from around the world have signed up to listen.
The webinar will, as the program attests, be a “year in review.” We will also try to look into our crystal ball and see what lies ahead, although we have reached out to colleagues at FDA to see what they might allow us to share.
Hopefully, you can join us on the 30th. Click here to register.